What are Bio-Rad Laboratories, Inc.'s profit margins?

Bio-Rad Laboratories, Inc. (BIO.B) runs a 51.9% gross margin and a 8.8% operating margin, with a 6.5% net margin.

Where do Bio-Rad Laboratories, Inc.'s ratios come from?

Every ratio is computed from Bio-Rad Laboratories, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Bio-Rad Laboratories, Inc. BIO.B Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Gross margin	51.9%-1.6pp	51.9%-1.9pp	52.3%-2.1pp	52.8%-1.1pp	53.5%+0.1pp
Net margin	6.5%+91.7pp	29.4%+101pp	-26.4%+3.8pp	12.5%+64.2pp	-85.2%-72.8pp
Free cash flow margin	13.8%-0.2pp	14.5%+3.2pp	13.2%+3.6pp	14.5%+7.6pp	14%—
Returns
Return on equity	2.5%+30.0pp	10.8%+34.9pp	-9.5%+0.3pp	4.6%+22.0pp	-27.5%-24.1pp
Return on assets	1.7%+21.3pp	7.6%+24.6pp	-6.7%+0.3pp	3.2%+15.4pp	-19.6%-17.1pp
Return on invested capital	11.4%+8.6pp	10.7%+7.6pp	2.8%-0.7pp	2%-1.9pp	2.8%-0.3pp
Efficiency
Asset turnover	0.3×0.0×	0.3×0.0×	0.3×0.0×	0.3×0.0×	0.2×0.0×
Inventory turnover	1.6×+0.1×	1.7×+0.1×	1.5×0.0×	1.5×0.0×	1.5×-0.1×
Liquidity
Current ratio	3.2×-2.8×	5.6×-0.9×	5.4×-0.7×	5.1×-1.2×	6×-0.6×
Quick ratio	2.4×-2.1×	4.2×-0.7×	3.9×-0.6×	3.7×-1.0×	4.4×-0.5×
Cash ratio	0.6×-0.5×	1×0.0×	0.8×-0.1×	0.7×-0.2×	1×+0.1×
Leverage
Debt-to-equity	0.1×-0.1×	0.2×0.0×	0.2×0.0×	0.2×0.0×	0.2×+0.1×
Debt-to-assets	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×
Interest coverage	22.7×+17.6×	22.6×+17.1×	4.6×-1.7×	4.6×-2.2×	5.1×-1.4×
Per Share
Book value per share	$254.15+6.4%	$273.22+17.3%	$250.22-6.5%	$261.82+9.7%	$238.93-24.7%
Valuation
Market capitalization	$7.52B+10.3%	$8.17B-11.1%	$7.59B-18.6%	$6.47B-16.9%	$6.82B-30.8%
Enterprise value	$8B+4.2%	$9.03B-10.5%	$8.59B-16.6%	$7.52B-14.4%	$7.68B-29.2%
Price / sales	2.9×+0.2×	3.2×-0.4×	3×-0.6×	2.5×-0.5×	2.7×-1.1×
Price / book	1.1×+0.1×	1.1×-0.3×	1.1×-0.1×	0.9×-0.2×	1×-0.1×
EV / sales	3.1×+0.1×	3.5×-0.4×	3.4×-0.6×	2.9×-0.5×	3×-1.1×
Free cash flow yield	4.7%-0.5pp	4.6%+1.4pp	4.4%+1.8pp	5.7%+3.5pp	5.2%—
Earnings yield	2.2%+34.0pp	9.3%+29.3pp	-8.9%-0.6pp	4.9%+21.9pp	-31.7%-28.5pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Bio-Rad Laboratories, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Bio-Rad Laboratories, Inc.'s profit margins?: Bio-Rad Laboratories, Inc. (BIO.B) runs a 51.9% gross margin and a 8.8% operating margin, with a 6.5% net margin.
Where do Bio-Rad Laboratories, Inc.'s ratios come from?: Every ratio is computed from Bio-Rad Laboratories, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.